FDA Warns GSK's Zofran May Cause Abnormal Heart Rhythm
Results from a study on GlaxoSmithKline PLC's anti-nausea drug Zofran and its generic equivalents suggest that some intravenous use may affect the heart's electrical activity, leading to patients developing an abnormal,...To view the full article, register now.
Already a subscriber? Click here to view full article